Metyos
2023
Metyos produces a biosensor tracking real-time dynamic data in relation to kidney diseases. It enables continuous potassium monitoring, supporting clinicians in the management of patients at risk of electrolyte imbalance.
Website
More details...
Company Overview
CEO
Alexandre Boulanger
INVESTED IN
2023
SECTOR
Medtech
Why we invested
- High barrier to entry driven by proprietary IP and technology
- First-mover positioning in continuous potassium monitoring
- Founders with strong technical and clinical backgrounds
- CEO is a successful repeat entrepreneur with execution track record
- Large market opportunity across multiple high-risk patient populations